EUVIMED · CrossrefJournal
Molecular Neurodegeneration Advances
ISSN 3059-4944 · Springer Science and Business Media LLC
Latest articles
Tau ablation rewires brain cell programs in health and restores function in disease
A new translational architecture for protective and regenerative ocular gene therapy
Chimeric models of neurodegenerative diseases: from disease mechanisms to regenerative therapies
The role of lactate in Alzheimer’s disease: from controversies to therapeutic opportunities
Mild traumatic brain injury promotes chronic cerebrovascular inflammation and glymphatic suppression
From biology to therapy: advances in progranulin-related neurodegenerative diseases
Publisher Correction: A druggable link between the angiotensin receptor 1 and α-synuclein pathology revealed in scalable human cellular models of Parkinson’s disease
Targeting reverse electron transport preserves mitochondrial function and prevents dopaminergic neurodegeneration in Parkinson’s disease
The shell of the amyloid fibrils: new insight on fuzzy coat polymorphs and function in proteinopathies
Propagation of α-synuclein pathology: models, mechanisms and future goals
Inhibition of NF-κB signaling pathway facilitates amyloid-β clearance by kallikrein-related peptidase 7
Wild-type human α-synuclein induces progressive tau pathology in a disease-relevant mouse model of synucleinopathy
The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer’s disease
miRNA family miR-29 inhibits PINK1-PRKN signaling via ATG9A
STIP1/HOP promotes the formation of cytotoxic α-synuclein oligomers
Glial-specific and inducible full body C3 deficiency does not affect amyloid pathology in the AppNL−G−F mouse model of Alzheimer’s disease
ApoE expression across the CNS: Who, What, Where, When, and How (much)?
Toward nanomedicine-enabled RNA therapeutics for Alzheimer’s disease
Neuroinflammatory stress preferentially impacts synaptic MAPK signaling and mitochondria in excitatory neurons
Female-specific Cx3cr1-driven regulation of ALS and Alzheimer’s risk genes in tauopathy
Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer’s disease
Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer’s disease
Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12
C3 lowering in adult APP KI mice rescues synapses and spares cognitive decline
Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy
Uncovering plaque-glia niches in human Alzheimer’s disease brains using spatial transcriptomics
A new dawn in neurodegeneration research: MN advances
Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodents
The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease
Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection
EUVIMED